A 17-year-old male with acute myocarditis following mRNA-1273 vaccination in Japan

Vaccinations are the main tool being used to control the COVID-19 pandemic. When the Japanese Ministry of Health approved the Moderna mRNA-1273 vaccination in May 2021, it was limited to patients over 18 years old; however, using the additional data of efficacy and safety from clinical trials, vacci...

Descripción completa

Detalles Bibliográficos
Autores principales: Iwamuro, Ayumi, Sasa, Tomoki, Kawai, Takafumi, Taguchi, Mamoru, Izuhara, Masayasu, Uegaito, Takashi, Shioji, Keisuke
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Japanese College of Cardiology 2022
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9040371/
https://www.ncbi.nlm.nih.gov/pubmed/35495897
http://dx.doi.org/10.1016/j.jccase.2022.03.012

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9040371/
https://www.ncbi.nlm.nih.gov/pubmed/35495897
http://dx.doi.org/10.1016/j.jccase.2022.03.012

Ejemplares similares